A Rollover Study to Provide Continued Treatment With GSK2118436 to Subjects With BRAF Mutation-Positive Tumors
Clinical trial NCT01231594 · COMPLETED
Trial details
- NCT number
- NCT01231594
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-05
- Primary completion
- 2018-04-09
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.